In last trading session, Altimmune Inc (NASDAQ:ALT) saw 1.38 million shares changing hands with its beta currently measuring 0.07. Company’s recent per share price level of $6.88 trading at $0.09 or 1.33% at ring of the bell on the day assigns it a market valuation of $488.96M. That closing price of ALT’s stock is at a discount of -115.7% from its 52-week high price of $14.84 and is indicating a premium of 69.62% from its 52-week low price of $2.09. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.69 million shares which gives us an average trading volume of 2.29 million if we extend that period to 3-months.

For Altimmune Inc (ALT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.50. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.35 in the current quarter.

Altimmune Inc (NASDAQ:ALT) trade information

Upright in the green during last session for gaining 1.33%, in the last five days ALT remained trading in the green while hitting it’s week-highest on Tuesday, 10/15/24 when the stock touched $6.88 price level, adding 4.97% to its value on the day. Altimmune Inc’s shares saw a change of -38.84% in year-to-date performance and have moved 9.21% in past 5-day. Altimmune Inc (NASDAQ:ALT) showed a performance of -9.11% in past 30-days. Number of shares sold short was 22.4 million shares which calculate 9.3 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 25 to the stock, which implies a rise of 72.48% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 35. It follows that stock’s current price would drop -74.42% in reaching the projected high whereas dropping to the targeted low would mean a loss of -74.42% for stock’s current value.

Altimmune Inc (ALT) estimates and forecasts

Statistics highlight that Altimmune Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -0.43% of value to its shares in past 6 months, showing an annual growth rate of 4.20% while that of industry is 17.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -97.70% from the last financial year’s standing.

Company posted 362k and 37k of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 35.74% during past 5 years.

Altimmune Inc (NASDAQ:ALT)’s Major holders

Insiders are in possession of 0.80% of company’s total shares while institution are holding 60.75 percent of that, with stock having share float percentage of 61.24%. Investors also watch the number of corporate investors in a company very closely, which is 60.75% institutions for Altimmune Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at ALT for having 5.32 million shares of worth $35.39 million. And as of 2024-06-30, it was holding 7.5155 of the company’s outstanding shares.

The second largest institutional holder is VANGUARD GROUP INC, which was holding about 4.91 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.9301 of outstanding shares, having a total worth of $32.63 million.